NO983098D0 - Hudheftende farmas°ytisk preparat, spesielt transdermalt terapeutisk system for frigivelse av 17-<beta>-estradiol til den menneskelige organisme - Google Patents

Hudheftende farmas°ytisk preparat, spesielt transdermalt terapeutisk system for frigivelse av 17-<beta>-estradiol til den menneskelige organisme

Info

Publication number
NO983098D0
NO983098D0 NO983098A NO983098A NO983098D0 NO 983098 D0 NO983098 D0 NO 983098D0 NO 983098 A NO983098 A NO 983098A NO 983098 A NO983098 A NO 983098A NO 983098 D0 NO983098 D0 NO 983098D0
Authority
NO
Norway
Prior art keywords
estradiol
beta
release
pharmaceutical preparation
air humidity
Prior art date
Application number
NO983098A
Other languages
English (en)
Other versions
NO312878B1 (no
NO983098L (no
Inventor
Bodo Asmussen
Michael Horstmann
Original Assignee
Lohmann Therapie Syst Lts
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lohmann Therapie Syst Lts filed Critical Lohmann Therapie Syst Lts
Publication of NO983098D0 publication Critical patent/NO983098D0/no
Publication of NO983098L publication Critical patent/NO983098L/no
Publication of NO312878B1 publication Critical patent/NO312878B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Materials For Medical Uses (AREA)
NO19983098A 1996-01-08 1998-07-03 Hudheftende farmasöytisk preparat, fremgangsmåte for fremstilling av samme, samt anvendelse av slike preparater NO312878B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19600347A DE19600347A1 (de) 1996-01-08 1996-01-08 Hauthaftende pharmazeutische Zubereitung, insbesondere TTS zur Abgabe von 17-beta-Estradiol an den menschlichen Organismus
PCT/EP1996/005822 WO1997025077A1 (de) 1996-01-08 1996-12-23 HAUTHAFTENDE PHARMAZEUTISCHE ZUBEREITUNG, INSBESONDERE TTS ZUR ABGABE VON 17-β-ESTRADIOL AN DEN MENSCHLICHEN ORGANISMUS

Publications (3)

Publication Number Publication Date
NO983098D0 true NO983098D0 (no) 1998-07-03
NO983098L NO983098L (no) 1998-07-03
NO312878B1 NO312878B1 (no) 2002-07-15

Family

ID=7782261

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19983098A NO312878B1 (no) 1996-01-08 1998-07-03 Hudheftende farmasöytisk preparat, fremgangsmåte for fremstilling av samme, samt anvendelse av slike preparater

Country Status (21)

Country Link
US (1) US6267982B1 (no)
EP (1) EP0880366B1 (no)
JP (1) JP2000505071A (no)
KR (1) KR100476579B1 (no)
CN (1) CN1107525C (no)
AT (1) ATE205406T1 (no)
AU (1) AU721677B2 (no)
CA (1) CA2242577C (no)
CZ (1) CZ289291B6 (no)
DE (2) DE19600347A1 (no)
DK (1) DK0880366T3 (no)
ES (1) ES2164270T3 (no)
HU (1) HUP9901102A3 (no)
IL (1) IL125160A (no)
MY (1) MY129733A (no)
NO (1) NO312878B1 (no)
NZ (1) NZ325817A (no)
PL (1) PL187275B1 (no)
SK (1) SK282984B6 (no)
WO (1) WO1997025077A1 (no)
ZA (1) ZA97111B (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6623763B2 (en) * 1996-01-08 2003-09-23 Lts Lohmann Therape-System Ag Pharmaceutical preparation adhering to the skin, in particular a transdermal therapeutic system for the release of 17-β-estradiol to the human organism
ATE526022T1 (de) * 1998-04-20 2011-10-15 Eisai R&D Man Co Ltd Stabilisierte zusammenstellungen die benzimidazole enthalten
DE19827732A1 (de) * 1998-06-22 1999-12-23 Rottapharm Bv Transdermales System vom Matrix-Typ zur Abgabe von Wirkstoffen mit einer hohen Abgaberate von Steroid-Hormonen und die Verwendung eines derartigen Systems zur Hormonersatztherapie
US20030108964A1 (en) * 2000-03-02 2003-06-12 Andrea Leblanc Caspase-inhibitory-factor(cif)and uses thereof
JP4989892B2 (ja) * 2004-01-30 2012-08-01 久光製薬株式会社 貼付剤入り包装袋

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4863738A (en) * 1987-11-23 1989-09-05 Alza Corporation Skin permeation enhancer compositions using glycerol monooleate
WO1990009784A1 (en) * 1989-02-28 1990-09-07 Teijin Limited Poultice and preparation thereof
IT1253265B (it) * 1991-11-25 1995-07-14 Rotta Research Lab Preparato a matrice copolimerica adesiva a base acrilica per il rilascio transdermico dell'estradiolo.
DE4223360C1 (no) * 1992-07-16 1993-04-08 Lts Lohmann Therapie-Systeme Gmbh & Co Kg, 5450 Neuwied, De
DE4237453C1 (no) * 1992-11-06 1993-08-19 Lts Lohmann Therapie-Systeme Gmbh & Co Kg, 5450 Neuwied, De
DE4405899A1 (de) * 1994-02-18 1995-08-24 Schering Ag Mittel zur transdermalen Applikation enthaltend Desogestrel
DE4429664C2 (de) * 1994-08-20 1997-09-11 Lohmann Therapie Syst Lts Estradiol-TTS mit wasserbindenden Zusätzen und Verfahren zu seiner Herstellung
DE4429667C2 (de) * 1994-08-20 1996-07-11 Lohmann Therapie Syst Lts Estradiol-TTS mit wasserbindenden Zusätzen und Verfahren zu seiner Herstellung

Also Published As

Publication number Publication date
ES2164270T3 (es) 2002-02-16
HUP9901102A2 (hu) 1999-08-30
KR100476579B1 (ko) 2005-09-26
ZA97111B (en) 1997-08-18
CZ214098A3 (cs) 1998-11-11
US6267982B1 (en) 2001-07-31
DK0880366T3 (da) 2001-12-27
DE19600347A1 (de) 1997-07-10
PL327940A1 (en) 1999-01-04
SK282984B6 (sk) 2003-01-09
AU1305797A (en) 1997-08-01
KR19990077110A (ko) 1999-10-25
CA2242577C (en) 2006-06-06
EP0880366B1 (de) 2001-09-12
IL125160A (en) 2003-01-12
DE59607696D1 (de) 2001-10-18
AU721677B2 (en) 2000-07-13
MY129733A (en) 2007-04-30
NZ325817A (en) 1999-01-28
CZ289291B6 (cs) 2001-12-12
CA2242577A1 (en) 1997-07-17
CN1207049A (zh) 1999-02-03
HUP9901102A3 (en) 1999-11-29
NO312878B1 (no) 2002-07-15
SK90898A3 (en) 1999-01-11
PL187275B1 (pl) 2004-06-30
CN1107525C (zh) 2003-05-07
WO1997025077A1 (de) 1997-07-17
NO983098L (no) 1998-07-03
EP0880366A1 (de) 1998-12-02
JP2000505071A (ja) 2000-04-25
IL125160A0 (en) 1999-01-26
ATE205406T1 (de) 2001-09-15

Similar Documents

Publication Publication Date Title
AU760588B2 (en) Pressure sensitive adhesive matrix patch for the treatment of onychomycosis
RU2176499C2 (ru) Композиция для чрескожного введения стероидных лекарственных средств и содержащий ее препарат
PT87125A (pt) Process for preparing transdermal therapeutic systems for combined administration of oestrogens and gestagens
JP2008517934A5 (no)
NZ228826A (en) Transdermal adhesive medicament containing eucalyptol (1,8 cineol)
GR3029308T3 (en) Medical device for the administration of active ingredients or drugs at very low doses, particularly homeopathic drugs.
FI952115A0 (fi) Trandermaalinen terapeuttinen menetelmä 17-beta-estradiolin antamiseen ja menetelmä järjestelmän valmistamiseksi
NO951523L (no) Plaster for transdermal administrering av flyktige, farmasöytisk aktive, kjemisk basiske bestanddeler, samt fremgangsmåte for fremstilling av plasteret
KR100281235B1 (ko) 활성성분으로서 17-β-에스트라디올 무수물을 함유하는 경피치료계
SE8401113L (sv) Forfarande for framstellning av pa huden fixerbara, krampstillande produkter, i synnerhet muskelkrampstillande
FI107705B (fi) Lanoliinijohdannaiset penetraatiota edistävinä aineina ja niiden käyttö lääkeaineita tai muita biologisesti aktiivisia aineita sisältävissä valmisteissa
AU709288B2 (en) Transdermal therapeutic system (tts) for the administration of drugs for treatment of drug dependency or drug addiction
NO983098D0 (no) Hudheftende farmas°ytisk preparat, spesielt transdermalt terapeutisk system for frigivelse av 17-&lt;beta&gt;-estradiol til den menneskelige organisme
Aqil et al. Fabrication and evaluation of polymeric films for transdermal delivery of pinacidil
JPH04505333A (ja) ロリプラムを含有する皮膚浸透移行性適用剤
KR20000029523A (ko) 치매치료및(또는)예방용제제
KR100272043B1 (ko) 알쯔하이머성 치매치료용 경피흡수제제
RU2001102050A (ru) Лекарственная форма
AU2003235046A1 (en) Pressure sensitive adhesive matrix patch for the treatment of onychomycosis
MX9804617A (es) Preparacion farmaceutica estabilizada en la superficie para aplicarse sobre la piel.

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees